[1] |
He X, Dong Y, Wu CW, et al. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating oncogene BMI-1 polycomb ring finger oncogene[J]. Mol Med, 2013, 18:1491-8.
|
[2] |
Liu YL, Zhao FL, Wang XS. Analysis of clinicopathologic features and prognosis in 2414 patients with rectal cancer[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2010,13(12): 913-6. [刘彦 龙, 赵发林, 王锡山. 2414例直肠癌患者的临床病理特征及预后 分析[J] 中华胃肠外科,2010,13(12):913-6.]
|
[3] |
Chen X, Guo X, Zhang H, et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis[J]. Oncogene, 2009, 28(10): 1385-92.
|
[4] |
Liu L, Chen L, Xu Y, et al. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells[J]. Biochem Biophys Res Commun, 2010, 400(2): 236-40.
|
[5] |
Liang L, Li X, Zhang X, et al. microRNA-137, a HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2[J]. Gastroenterology, 2013,144(3): 62 4-35.e4.
|
[6] |
Chao A, Lin CY, Lee YS, et al. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2[J]. Oncogene,2012, 31(6):764-75.
|
[7] |
Mulrane L, Madden SF, Brennan DJ, et al. miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro[J]. Clin Cancer Res, 2012, 18 (24):6702-13.
|
[8] |
Fuse M, Kojima S, Enokida H,et al. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer[J]. J Hum Genet, 2012, 57(11):691-9.
|
[9] |
Schultz NA, Andersen KK, Roslind A, et al. Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--fi ve microRNAs in a prognostic index[J]. World J Surg, 20 12, 36(11):2699-707.
|
[10] |
Liu H, Zhu L, Liu B, et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer[J]. Cancer Lett, 2012, 316(2):196-203.
|
[11] |
Ho CY, Bar E, Giannini C,et al. MicroRNA profi ling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2[J]. Neuro Oncol, 2013, 15 (1):69-82.
|
[12] |
Zhang Y,Takahashi S,Tasaka A,et al.Involvement of microRNA-224 in cell proliferation, migration, invasion, and antiapoptosis in hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 20 13, 28(3):565-75.
|
[13] |
Shen SN, Wang LF, Jia YF, et al. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer[J]. Diagn Pathol,2013,8:69.
|
[14] |
Lu S, Wang S, Geng S, et al. Upregulation of microRNA-224 confers a poor prognosis in glioma patients[J]. Clin Transl Oncol,2013,15(7):569-74.
|
[15] |
Zhou F, Li S, Meng HM,et al. MicroRNA and histopathological characterization of pure mucinous breast carcinoma[J]. Cancer Biol Med,2013,10(1):22-7.
|
[16] |
Mavridis K, Stravodimos K, Scorilas A. Downregulation and prognostic performance of microRNA 224 expression in prostate cancer[J]. Clin Chem, 2013, 59(1):261-9.
|
[17] |
Fu J, Tang W, Du P, et al. Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis[J]. BMC Syst Biol,2012,6:68.
|
[18] |
Vega AB, Pericay C, Moya I, et al. microRNA expression profi le in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers[J]. Oncol Rep,2013,30(1):320-6.
|
[19] |
Olaru AV, Yamanaka S, Vazquez C, et al. MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease[J]. Inflamm Bowel Dis,2013,19(3):471-80.
|
[20] |
Wang Y, Lee AT, Ma JZ, et al. Profi ling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specifi c target[J]. J Biol Chem,2008, 283(19):13205-15.
|
[21] |
Li Q, Wang G, Shan JL, et al. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion[J]. J Gastroenterol Hepatol,2010, 25(1):164-71.
|